VTVT
Income statement / Annual
Last year (2023), vTv Therapeutics Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, vTv Therapeutics Inc.'s net income was -$20.25 M.
See vTv Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00 |
$2.02 M |
$4.01 M |
$6.41 M |
$2.76 M |
$12.43 M |
$291,000.00 |
$634,000.00 |
$519,000.00 |
$1.55 M |
Cost of Revenue |
$13.60 M
|
$92,000.00
|
$89,000.00
|
$11.02 M
|
$15.12 M
|
$23.04 M
|
$39.64 M
|
$45.75 M
|
$29.58 M
|
$18.73 M
|
Gross Profit |
-$13.60 M
|
$1.93 M
|
$3.92 M
|
-$4.60 M
|
-$12.36 M
|
-$10.60 M
|
-$39.35 M
|
-$45.11 M
|
-$29.07 M
|
-$17.18 M
|
Gross Profit Ratio |
0
|
0.95
|
0.98
|
-0.72
|
-4.47
|
-0.85
|
-135.22
|
-71.16
|
-56
|
-11.09
|
Research and Development Expenses |
$13.51 M
|
$12.36 M
|
$13.32 M
|
$11.02 M
|
$15.12 M
|
$23.04 M
|
$39.64 M
|
$45.75 M
|
$29.58 M
|
$18.73 M
|
General & Administrative Expenses |
$11.91 M
|
$12.20 M
|
$12.34 M
|
$7.25 M
|
$8.54 M
|
$9.22 M
|
$11.33 M
|
$9.91 M
|
$9.08 M
|
$11.72 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$11.91 M
|
$12.20 M
|
$12.34 M
|
$7.25 M
|
$8.54 M
|
$9.22 M
|
$11.33 M
|
$9.91 M
|
$9.08 M
|
$11.72 M
|
Other Expenses |
-$13.51 M
|
-$2.67 M
|
$4.06 M
|
-$270,000.00
|
$828,000.00
|
-$592,000.00
|
-$190,000.00
|
-$22,000.00
|
-$2.97 M
|
-$1.13 M
|
Operating Expenses |
$11.91 M
|
$24.56 M
|
$25.67 M
|
$18.27 M
|
$23.66 M
|
$32.26 M
|
$50.97 M
|
$55.65 M
|
$38.66 M
|
$30.45 M
|
Cost And Expenses |
$25.50 M
|
$24.56 M
|
$25.67 M
|
$18.27 M
|
$23.66 M
|
$32.26 M
|
$50.97 M
|
$55.65 M
|
$38.66 M
|
$30.45 M
|
Interest Income |
$472,000.00
|
$352,000.00
|
$1,000.00
|
$12,000.00
|
$53,000.00
|
$61,000.00
|
$117,000.00
|
$87,000.00
|
$0.00
|
$0.00
|
Interest Expense |
$13,000.00
|
$15,000.00
|
$12,000.00
|
$692,000.00
|
$1.83 M
|
$3.29 M
|
$3.09 M
|
$398,000.00
|
$1.74 M
|
$6.01 M
|
Depreciation & Amortization |
$90,000.00
|
$92,000.00
|
$89,000.00
|
$94,000.00
|
$39,000.00
|
$218,000.00
|
$197,000.00
|
$265,000.00
|
$501,000.00
|
$864,000.00
|
EBITDA |
-$25.41 M |
-$24.77 M |
-$17.52 M |
-$12.02 M |
-$19.97 M |
-$20.14 M |
-$50.56 M |
-$54.69 M |
-$38.87 M |
-$29.23 M |
EBITDA Ratio |
0
|
-12.32
|
-4.4
|
-1.89
|
-7.24
|
-1.64
|
-174.42
|
-86.68
|
-73.49
|
-18.82
|
Operating Income Ratio |
0
|
-11.17
|
-5.41
|
-1.85
|
-7.56
|
-1.59
|
-174.16
|
-86.78
|
-73.49
|
-18.66
|
Total Other Income/Expenses Net |
-$464,000.00
|
-$2.33 M
|
$4.05 M
|
-$950,000.00
|
-$946,000.00
|
-$3.82 M
|
-$3.17 M
|
-$333,000.00
|
-$2.97 M
|
-$7.20 M
|
Income Before Tax |
-$25.97 M
|
-$24.87 M
|
-$17.62 M
|
-$12.80 M
|
-$21.84 M
|
-$23.65 M
|
-$53.85 M
|
-$55.35 M
|
-$41.11 M
|
-$36.10 M
|
Income Before Tax Ratio |
0
|
-12.33
|
-4.4
|
-2
|
-7.9
|
-1.9
|
-185.04
|
-87.31
|
-79.2
|
-23.31
|
Income Tax Expense |
$0.00
|
$200,000.00
|
$115,000.00
|
-$3.98 M
|
$100,000.00
|
$200,000.00
|
$800,000.00
|
-$39.00 M
|
-$14.11 M
|
$4.88 M
|
Net Income |
-$20.25 M
|
-$25.07 M
|
-$17.73 M
|
-$8.83 M
|
-$21.94 M
|
-$7.91 M
|
-$16.14 M
|
-$16.35 M
|
-$27.50 M
|
-$36.10 M
|
Net Income Ratio |
0
|
-12.42
|
-4.43
|
-1.38
|
-7.94
|
-0.64
|
-55.48
|
-25.79
|
-52.98
|
-23.31
|
EPS |
-9.71 |
-13.06 |
-11.32 |
-7.49 |
-28.97 |
-25.42 |
-66.62 |
-68.52 |
-132.9 |
-173.87 |
EPS Diluted |
-9.71 |
-13.06 |
-11.32 |
-7.49 |
-28.97 |
-25.42 |
-66.62 |
-68.52 |
-132.9 |
-173.87 |
Weighted Average Shares Out |
$2.08 M
|
$1.92 M
|
$1.57 M
|
$1.18 M
|
$757,301.00
|
$311,231.00
|
$242,330.00
|
$238,638.00
|
$206,913.00
|
$207,633.00
|
Weighted Average Shares Out Diluted |
$2.08 M
|
$1.92 M
|
$1.57 M
|
$1.18 M
|
$757,301.00
|
$311,231.00
|
$242,331.00
|
$238,638.00
|
$206,913.00
|
$207,633.00
|
Link |
|
|
|
|
|
|
|
|
|
|